Scree. Test. Treat.

Every DTC program begins with the same clinical principle: identify risk earlier, confirm it when appropriate, and guide the patient toward timely care.

Screen. DTC starts with TriageIQ™, our proprietary universal chronic-risk pre-screener designed to identify neurological, cardiometabolic, behavioral, functional, and lower-extremity risk signals at intake. In just minutes, TriageIQ™ helps providers uncover patient-reported concerns that may otherwise go undetected during a routine visit.

Test. When risk signals are identified, providers may determine whether focused, non-invasive testing is clinically appropriate. DTC supports rapid point-of-care assessment pathways for neuropathy, vascular disease, cognitive risk, cardiometabolic risk, balance concerns, wound risk, and other chronic-disease indicators. These testing pathways are designed to support documentation, medical necessity, and payer-aligned clinical workflows when applicable.

Treat. Once risk is identified and documented, DTC helps clinics connect patients to appropriate next steps. This may include therapy pathways, care management, monitoring, patient education, referral, wound-care support, chronic-care coordination, or continued follow-up based on the provider’s clinical judgment. Together, Screen. Test. Treat. turns routine intake into a practical chronic-risk system.

Each DTC program is turnkey, clinic-friendly, and designed to be deployed with minimal disruption. Programs may be implemented inside a single exam room and can support existing primary care, specialty care, chronic-care, mobile, remote, and wellness workflows.

The goal is simple: help providers find hidden risk earlier, document it more clearly, act on it faster, and help patients avoid preventable complications before damage becomes irreversible.

Go Beyond Blood Sugars